Ventilator-associated pneumonia is an important risk factor for mortality after major cardiac surgery

Journal of Critical Care

Volumn 27, Issue 1, 2012, Pages 18-25

  Tamayo, Eduardo ^a   Álvarez, Francisco Javier ^b   Martínez Rafael, Beatriz ^a   Bustamante, Juan ^c   Bermejo Martin, Jesus F ^a   Fierro, Inma ^b   Eiros, Jose Maria ^a   Castrodeza, Javier ^d   Heredia, Maria ^a   Gómez Herreras, José I ^e  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d GERENCIA REGIONAL DE SALUD DE CASTILLA Y LEÓN   (Spain)

^e HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; In hospital mortality; Nosocomial pneumonia; Risk factors; Ventilator associated pneumonia

Indexed keywords

AMIKACIN; CEFEPIME; CHLORHEXIDINE; CIPROFLOXACIN; IMIPENEM; LINEZOLID; PIPERACILLIN PLUS TAZOBACTAM; RANITIDINE; SUCRALFATE; TEICOPLANIN;

ACINETOBACTER; ACUTE KIDNEY FAILURE; AGE; AGED; ANTIBIOTIC THERAPY; AORTA CLAMPING; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BLEEDING; CARDIOPULMONARY BYPASS; CARDIOPULMONARY BYPASS TIME; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; ESCHERICHIA COLI; FEMALE; GASTROINTESTINAL SYMPTOM; GENDER; HAEMOPHILUS INFLUENZAE TYPE A; HEART SURGERY; HEART VALVE SURGERY; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; KLEBSIELLA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDIASTINUM; MEDIASTINUM HEMORRHAGE; MEDICAL HISTORY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MORTALITY; OBESITY; OBSERVATIONAL STUDY; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; PROTEUS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PNEUMONIA; RESPIRATORY FAILURE; RISK FACTOR; SERRATIA; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; SURVIVOR; TIME; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA; YEAST;

AGED; CARDIOPULMONARY BYPASS; CROSS INFECTION; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84856480570     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2011.03.008     Document Type: Article

References (43)

1. Kollef M.H. Ventilator-associated pneumonia: a multivariate analysis. JAMA 1993, 270:1965-1970.
2. Rebollo M.H., Bernal J.M., Llorca J., Rabasa J.M., Revuelta J.M. Nosocomial infections in patients having cardiovascular operations: a multivariate analysis of risk factors. J Thorac Cardiovasc Surg 1996, 112:908-913.
3. Bouza E., Pérez A., Muñoz P., Jesús Pérez M., Rincón C., Sánchez C., et al. Ventilator-associated pneumonia after heart surgery: a prospective analysis and the value of surveillance. Crit Care Med 2003, 31:1964-1970. Cardiovascular Infection Study Group.
4. Rello J., Ollendorf D.A., Oster G., Vera-Llonch M., Bellm L., Redman R., et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002, 122:2115-2121.
5. Bercault N., Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med 2001, 29:2303-2309.
6. Warren D.K., Shukla S.J., Olsen M.A., Kollef M.H., Hollenbeak C.S., Cox M.J., et al. Outcome and attributable cost of ventilator associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003, 31:1312-1317.
7. Fagon J.Y., Chastre J., Hance A.J., Montravers P., Novara A., Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993, 94:281-288.
8. Gross P.A., Van Antwerpen C. Nosocomial infections and hospital deaths: a case control study. Am J Med 1983, 75:658-661.
9. Craig C.P., Connelly S. Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality. Am J Infect Control 1993, 12:233-238.
10. Craven D.E., Kunches L.M., Lichtenburg D.A., Kollisch N.R., Barry M.A., McCabe W.R Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med 1988, 148:1161-1168.
11. Craven D.E., Kunches L.M., Kilinsky V., Lichtenberg D.A., Make B.J., McCabe W.R. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986, 133:792-796.
12. Vincent J.L., Bihari P.M., Suter H.A., Bruining J., White M.H., Nicolas-Chanion M., et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European prevalence of infection in intensive care (EPIC) study. JAMA 1995, 274:639-644.
13. Fagon J.Y., Chastre J., Vuagnat A., Trouillet J.L., Novara A., Gibert C. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996, 275:866-869.
14. Papazian L., Bregeon X., Thirion R. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996, 154:91-97.
15. Bueno-Cavanillas R., Delgado-Rodriguez A., Lopez-Luque S., Schaffino-Cana S., Galvez-Vargas R. Influence of nosocomial infection on mortality rate in an intensive care unit. Crit Care Med 1994, 22:55-60.
16. Vallés J., Pobo A., García-Esquirol O., Mariscal D., Real J., Fernández R. Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early vs late onset. Intensive Care Med 2007, 33:1363-1368.
17. Melsen W.G., Rovers M.M., Bonten M.J. Ventilator-associated pneumonia and mortality: a systematic review of observational studies. Crit Care Med 2009, 37:2709-2718.
18. Leal-Noval S.R., Marquez-Vácaro J.A., García-Curiel A., Camacho-Laraña P., Rincón-Ferrari M.D., Ordoñez-Fernández A., et al. Nosocomial pneumonia in patients undergoing heart surgery. Crit Care Med 2000, 28:935-940.
19. Tamayo E., Gualis J., Florez S., Castrodeza J., Eiros J.M., Alvarez J. Comparative study of single-dose and 24-hour multiple-dose antibiotic prophylaxis for cardiac surgery. J Thorac Cardiovasc Surg 2008, 136:1522-1527.
20. Tobin M.J. Advances in mechanical ventilation. N Engl J Med 2001, 344:1986-1996.
21. Kollef M.H. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000, 31:S131-S138.
22. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections. Am J Infect Control 1988, 16:128-140.
23. Pugin J., Auckenthaler R., Mili N., Janssens J.P., Lew P.D., Suter P.M. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991, 143:1121-1129.
24. El-Hamamsy I., Cartier R., Demers P., Bouchard D., Pellerin M. Long-term results after systematic off-pump coronary artery bypass graft surgery in 1000 consecutive patients. Circulation 2006, 114:486-491.
25. van Swieten J.C., Koudstaal P.J., Visser M.C., Schouten H.J., van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988, 19:604-607.
26. Filsoufi F., Rahmanian P.B., Castillo J.G., Mechanick J.I., Sharma S.K., Adams D.H. Diabetes is not a risk factor for hospital mortality following contemporary coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 2007, 6:753-758.
27. Puskas J.D., Williams W.H., Mahoney E.M., Huber P.R., Block P.C., Duke P.G., et al. Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. JAMA 2004, 291:1841-1849.
28. Allison P.D. Logistic regression using the SAS system: theory and application 1999, SAS Institute, Inc, Cary, NC.
29. Belsley D.A., Kuh E., Welsch R.E. Regression diagnostics: identifying influential data and sources of collinearity 1980, John Wiley and Sons, Inc, New York, NY.
30. Kleinbaum D.G., Kleinbaum D.G., Muller K.E. Applied regression analysis and other multivariable methods. Pacific Grove 1998, Duxbury Press, CA.
31. Cox D.R. Regression models and life tables. J R Stat Soc 1972, 34:187-220.
32. Tuman M.D., Mc Carthy R.J., March R.J., Najafe H., Ivankovich A.D. Morbidity and duration of ICU stay after cardiac surgery. A model for preoperative risk assessment. Chest 1992, 102:36-44.
33. Nashef S.A., Roques F., Michel P., Gauducheau E., Lemeshow S., Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999, 16:9-13.
34. Parsonnet V., Dean D., Bernstein A.D. A method of uniform stratification of risk for evaluating the results surgery in acquired adult heart disease. Circulation 1989, 79:I3-I12.
35. Nashef S.A., Roques F., Hammill B.G., Peterson E.D., Michel P., Grover F.L., et al. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 2002, 22:101-105. EurpSCORE Project Group.
36. Toumpoulis I.K., Anagnostopoulos C.E., DeRose J.J., Swistel D.G. European system for cardiac operative risk evaluation predicts long-term survival in patients with coronary artery bypass grafting. Eur J Cardiothorac Surg 2004, 25:51-58.
37. Morris A.C., Kefala K., Simpson A.J., Wilkinson T.S., Everingham K., Kerslake D., et al. Evaluation of the effect of diagnostic methodology on the reported incidence of ventilator-associated pneumonia. Thorax 2009, 64:516-522.
38. Kollef M.H., Sharpless L., Vlasnik J., Pasque C., Murphy D., Fraser V.J. The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest 1997, 112:666-675.
39. Hortal J., Giannella M., Pérez M.J., Barrio J.M., Desco M., Bouza E., et al. Incidence and risk factors for ventilator-associated pneumonia after major heart surgery. Intensive Care Med 2009, 35:1518-1525.
40. Hortal J., Muñoz P., Cuerpo G., Litvan H., Rosseel P.M., Bouza E. Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe. European Study Group on Nosocomial Infections; European Workgroup of Cardiothoracic Intensivists. Crit Care 2009, 13(3):R80.
41. Kollef M.H., Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998, 113:412-420.
42. Moine P., Timsit J.F., Lassencede A., Troche G., Fosse J.P., Alberti C., et al. Mortality associated with late onset pneumonia in the intensive care unit:results of multi-center cohort study. Intensive Care Med 2002, 28:154-163. The OUTCOMERA study group.
43. Leroy O., Meybeck A., d'Escrivan T., Devos P., Kipnis E., Georges H. Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia. Intensive Care Med 2003, 29:2170-2173.